Adventhealth Primary Care Network Inc | |
900 Hope Way Altamonte Springs FL 32714-1502 | |
(407) 357-1000 | |
Not Available |
Full Name | Adventhealth Primary Care Network Inc |
---|---|
Speciality | Family Medicine |
Location | 900 Hope Way, Altamonte Springs, Florida |
Authorized Official Name and Position | Kelly J Pettijohn (SVP-CFO) |
Authorized Official Contact | 4073571000 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Adventhealth Primary Care Network Inc 900 Hope Way Altamonte Springs FL 32714-1502 Ph: (407) 357-1000 | Adventhealth Primary Care Network Inc 900 Hope Way Altamonte Springs FL 32714-1502 Ph: (407) 357-1000 |
NPI Number | 1093493637 |
---|---|
Provider Enumeration Date | 07/05/2023 |
Last Update Date | 09/15/2023 |
Medicare PECOS PAC ID | 1557722410 |
---|---|
Medicare Enrollment ID | O20230725004134 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1093493637 | NPI | - | NPPES |
Provider Name | Mark Lee Craft |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1689657926 PECOS PAC ID: 5496669178 Enrollment ID: I20031117000781 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | April Dawn Morris |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1538129705 PECOS PAC ID: 5991604654 Enrollment ID: I20040102000223 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Edward Scanlan |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1861475196 PECOS PAC ID: 4981591989 Enrollment ID: I20040303001014 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Adina M Ion |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1144330119 PECOS PAC ID: 3577451657 Enrollment ID: I20040309001295 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Andrew D Tagle |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1831161140 PECOS PAC ID: 2062304835 Enrollment ID: I20040326000463 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Michele Hornstein |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1972542256 PECOS PAC ID: 1759374184 Enrollment ID: I20040403000023 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Randi Ann Rodrigues |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1023003100 PECOS PAC ID: 5890789853 Enrollment ID: I20040413000137 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jose O Delgado |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1801889688 PECOS PAC ID: 6507850138 Enrollment ID: I20040414001150 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | William C Douglass |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1396713087 PECOS PAC ID: 8426039553 Enrollment ID: I20040525001788 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Sergey Turchin |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1033177878 PECOS PAC ID: 2961480728 Enrollment ID: I20040709000226 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Gregory A Berland |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1265427405 PECOS PAC ID: 5597744797 Enrollment ID: I20040720000091 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jessy Casimiro |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1639157902 PECOS PAC ID: 5092779355 Enrollment ID: I20041116000834 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Luther St James |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1013105477 PECOS PAC ID: 3779547062 Enrollment ID: I20041116001070 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Carol Tanner St James |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1740478197 PECOS PAC ID: 5395709968 Enrollment ID: I20041116001134 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Kuchakulla N Reddy |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1255325171 PECOS PAC ID: 1850382326 Enrollment ID: I20041123000890 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Michael P Desouza |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1649292020 PECOS PAC ID: 4587614318 Enrollment ID: I20050128000427 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jerry W Bishop |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1982607875 PECOS PAC ID: 2961390760 Enrollment ID: I20050818000271 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Elizabeth A John |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1467557207 PECOS PAC ID: 9830120062 Enrollment ID: I20050829000060 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Debra Hastings |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1366441230 PECOS PAC ID: 0941225122 Enrollment ID: I20051006000604 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jin Y Soh Urbano |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1942240767 PECOS PAC ID: 6901823475 Enrollment ID: I20051025000445 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Michael E Townsend |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1427024504 PECOS PAC ID: 5193742567 Enrollment ID: I20051026000274 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Mark W Lastarza |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1831165448 PECOS PAC ID: 8426075706 Enrollment ID: I20051026000449 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Rosemarie A Latham |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1407925910 PECOS PAC ID: 1557381746 Enrollment ID: I20051202000284 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Herma L Baker |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1770568339 PECOS PAC ID: 2466473392 Enrollment ID: I20051207000719 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Mohammed Asif |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1811928674 PECOS PAC ID: 4082629209 Enrollment ID: I20060209000233 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Eric A Garcia |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1194774596 PECOS PAC ID: 6406868728 Enrollment ID: I20060630000286 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Danielle Lee Albritton |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1114969151 PECOS PAC ID: 8325051071 Enrollment ID: I20060724000238 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Joan D Coupland |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1366422933 PECOS PAC ID: 0244238251 Enrollment ID: I20061129000050 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Deborah I Greaves |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1174560163 PECOS PAC ID: 9931201878 Enrollment ID: I20070224000004 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Ivonne Johnson |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1407899412 PECOS PAC ID: 3678676251 Enrollment ID: I20070320000410 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Samuel P Shay |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1659326692 PECOS PAC ID: 9032000393 Enrollment ID: I20070405000005 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jecebu Ceballos |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1740394352 PECOS PAC ID: 6608973342 Enrollment ID: I20070515000245 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Svetlana Y Rogozina |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1568576437 PECOS PAC ID: 3971555640 Enrollment ID: I20070530000484 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Daniel L Cochran |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1770510372 PECOS PAC ID: 3173598034 Enrollment ID: I20070828000515 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jacquelyn H Nystrom |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1083818553 PECOS PAC ID: 8325132913 Enrollment ID: I20070913000035 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Tapan P Bhatt |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1164625281 PECOS PAC ID: 0749379451 Enrollment ID: I20071204000144 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jennifer J Schwertner |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1356538193 PECOS PAC ID: 4385729193 Enrollment ID: I20080304000445 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Shrish Calla |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1497976526 PECOS PAC ID: 6204907710 Enrollment ID: I20080611000184 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Kimberly Anne Keller |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1366481483 PECOS PAC ID: 7315995909 Enrollment ID: I20080618000253 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Pamela Lynn Menzel |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1477675718 PECOS PAC ID: 9436221918 Enrollment ID: I20080627000104 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Vivian M Theriault |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1740494962 PECOS PAC ID: 5890867857 Enrollment ID: I20080708000400 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Adela Marie Oliva |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1164535670 PECOS PAC ID: 2163597527 Enrollment ID: I20080819000696 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Perri L Dumbacher |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1497705131 PECOS PAC ID: 2466485495 Enrollment ID: I20081009000460 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jeffrey J Ward |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1093779175 PECOS PAC ID: 8224196738 Enrollment ID: I20081027000630 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Robert B Rosequist |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1699771071 PECOS PAC ID: 7618058892 Enrollment ID: I20090127000574 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Marcus J Merriweather |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1538343215 PECOS PAC ID: 7113083692 Enrollment ID: I20090309000133 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Regina J Asihene |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1598736886 PECOS PAC ID: 5193878189 Enrollment ID: I20090810000359 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Ananth Krishnan |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1073521902 PECOS PAC ID: 7416003629 Enrollment ID: I20090914000055 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Christine A Aziz |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1437354958 PECOS PAC ID: 5890835185 Enrollment ID: I20091217000292 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Joel M Weinberger |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1568411577 PECOS PAC ID: 6709937865 Enrollment ID: I20091222000441 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Hezi Cohen |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1265427587 PECOS PAC ID: 3678663341 Enrollment ID: I20091228000379 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Glenn I Lura |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1790747897 PECOS PAC ID: 1153463799 Enrollment ID: I20100120000820 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Karen Echeverria Beltran |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1376526194 PECOS PAC ID: 7416090329 Enrollment ID: I20100201000356 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Rae E Ringenberg |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1477500494 PECOS PAC ID: 7315080686 Enrollment ID: I20100209000330 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | James W Badman |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1265470405 PECOS PAC ID: 8325181621 Enrollment ID: I20100209000514 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Rachel Solomon |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1902849458 PECOS PAC ID: 2668516683 Enrollment ID: I20100215000312 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Victor A Rivera |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1316994395 PECOS PAC ID: 3779627799 Enrollment ID: I20100215000387 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Chuong H Vu |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1366484446 PECOS PAC ID: 0941344980 Enrollment ID: I20100215000512 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Lisa M Gonsalves |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1114997616 PECOS PAC ID: 4385789577 Enrollment ID: I20100226000146 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Johnna G Mantineo |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1952371312 PECOS PAC ID: 1951446194 Enrollment ID: I20100226000702 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | James Mcdonnell |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1396849915 PECOS PAC ID: 3870628720 Enrollment ID: I20100317000130 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Arthur R Polin |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1134224561 PECOS PAC ID: 5890820765 Enrollment ID: I20100317000460 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | James P Fischer |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1023113321 PECOS PAC ID: 9436284304 Enrollment ID: I20100317000502 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Hugh A Rutledge |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1437254885 PECOS PAC ID: 8527193499 Enrollment ID: I20100317000589 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Ruben E Perez |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1932178308 PECOS PAC ID: 4789719592 Enrollment ID: I20100318000626 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jaima Peyton Woodiwiss |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1902822323 PECOS PAC ID: 7911036512 Enrollment ID: I20100519000781 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Diego T Torres Ii |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1821093105 PECOS PAC ID: 7911991963 Enrollment ID: I20100607000631 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Reginald Schutt-aine |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1083672380 PECOS PAC ID: 4789684283 Enrollment ID: I20100629000196 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Thomas Jude Montaldo |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1003864992 PECOS PAC ID: 0244230746 Enrollment ID: I20100713000518 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Mary V Desario |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1720313539 PECOS PAC ID: 1557493152 Enrollment ID: I20100716000816 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Sharon M Sibley |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1700806502 PECOS PAC ID: 1355474248 Enrollment ID: I20100728001233 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Ram M Amilineni |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1457457541 PECOS PAC ID: 3971636515 Enrollment ID: I20100803000135 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jeffrey David Wartman |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1295730414 PECOS PAC ID: 7517857683 Enrollment ID: I20100817001432 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Steven L Attermann |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1538173026 PECOS PAC ID: 9234110362 Enrollment ID: I20100908001079 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Sage P Naran |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1407971807 PECOS PAC ID: 9234254459 Enrollment ID: I20100913000022 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Eddie Waldheim |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1881797082 PECOS PAC ID: 3476678962 Enrollment ID: I20100921001127 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Glenda F Parker |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1760521132 PECOS PAC ID: 3779679311 Enrollment ID: I20101004001328 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Donald W Liebelt |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1710969076 PECOS PAC ID: 7214908540 Enrollment ID: I20101015000781 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Laurence Neufeld |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1083694640 PECOS PAC ID: 7214827047 Enrollment ID: I20101026001076 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Tina L Fischer Carne |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1912995499 PECOS PAC ID: 2062508690 Enrollment ID: I20101101000196 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Margaret Ann Colleran |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1457356677 PECOS PAC ID: 9537293261 Enrollment ID: I20101124000711 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Cesar A Unyon |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1053396309 PECOS PAC ID: 9234326901 Enrollment ID: I20101207000608 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Alan J Iezzi |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1952590028 PECOS PAC ID: 6002866902 Enrollment ID: I20110209000518 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Steven L Clark |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1124125505 PECOS PAC ID: 4587847934 Enrollment ID: I20110323000492 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | John Morrison |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1396936936 PECOS PAC ID: 7618093584 Enrollment ID: I20110630000193 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Justin N Menezes |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1194013169 PECOS PAC ID: 4183895733 Enrollment ID: I20110912000757 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Rajani P Shah |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1710936695 PECOS PAC ID: 8820269004 Enrollment ID: I20110920000144 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Malika George |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1467603183 PECOS PAC ID: 8224209960 Enrollment ID: I20110929000112 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Cynthia P Roever |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1295976702 PECOS PAC ID: 3375715634 Enrollment ID: I20111010000178 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Tanam S Ahmed |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1043475155 PECOS PAC ID: 5890960157 Enrollment ID: I20111214001004 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jennifer K Naruta |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1710250600 PECOS PAC ID: 5496915050 Enrollment ID: I20120320000332 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Robert J Oliva |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1740393255 PECOS PAC ID: 7113180233 Enrollment ID: I20120627000053 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Gigi Kwok |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1821358433 PECOS PAC ID: 9830354521 Enrollment ID: I20120702000348 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Gretchen L Winans |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1568770691 PECOS PAC ID: 7416104617 Enrollment ID: I20120823000050 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Elizabeth B Sasse |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1427310440 PECOS PAC ID: 9931358561 Enrollment ID: I20120925000689 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Robert H Swietarski |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1790763332 PECOS PAC ID: 3274503115 Enrollment ID: I20121010000042 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Craig W Burns |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1982605523 PECOS PAC ID: 0244480572 Enrollment ID: I20121023000530 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Mercedes D Wierman |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1003188236 PECOS PAC ID: 0244481885 Enrollment ID: I20121108000301 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Aya Dawn Olejeme |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1144348434 PECOS PAC ID: 9234298423 Enrollment ID: I20121116000239 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Margarette Lespinasse |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1609112408 PECOS PAC ID: 6901059468 Enrollment ID: I20130111000147 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Kashif I Qureshi |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1215290382 PECOS PAC ID: 2365695632 Enrollment ID: I20130117000237 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Nancy L. Dahl |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1861743122 PECOS PAC ID: 4587818018 Enrollment ID: I20130208000053 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Karen L Steinbrick |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1710241229 PECOS PAC ID: 2062657513 Enrollment ID: I20130404000079 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Erdem M Aydur |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1881985026 PECOS PAC ID: 0547409013 Enrollment ID: I20130612000591 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Kathryn M Malan |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1740575497 PECOS PAC ID: 5496992778 Enrollment ID: I20130812000482 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jill M Stephens |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1437582392 PECOS PAC ID: 3779718770 Enrollment ID: I20131029001185 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Sarah D Mehuron |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1255620084 PECOS PAC ID: 1355576182 Enrollment ID: I20131031001661 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Veronica L Chastain |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1730400060 PECOS PAC ID: 9638304272 Enrollment ID: I20131106001465 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Kelly A Doggett |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1669818175 PECOS PAC ID: 0749415347 Enrollment ID: I20131107001305 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Romeena Tejiram Martinez |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1679810212 PECOS PAC ID: 9830325596 Enrollment ID: I20131202001263 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Zofia Kletter |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1477978674 PECOS PAC ID: 3577795913 Enrollment ID: I20140417000146 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jennifer Ann Meeks |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1720347651 PECOS PAC ID: 8022246917 Enrollment ID: I20140821001218 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Amit D Desai |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1447545850 PECOS PAC ID: 2264669142 Enrollment ID: I20140917001427 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jonathan Screnock |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1285677294 PECOS PAC ID: 9537155239 Enrollment ID: I20140917002269 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Lana Ann Doxtater Massaro |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1548374663 PECOS PAC ID: 8426155318 Enrollment ID: I20141014002441 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jodi L Parker |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1164826731 PECOS PAC ID: 4880916949 Enrollment ID: I20141201001791 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Roxann Rodriguez |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1710327622 PECOS PAC ID: 0941524573 Enrollment ID: I20150130000615 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Hossam S Naguib |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1235188087 PECOS PAC ID: 5698675403 Enrollment ID: I20150505001666 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Belinda Joy Gavino |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1750711636 PECOS PAC ID: 4981918968 Enrollment ID: I20150804005720 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Marie M Collazo |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1346640356 PECOS PAC ID: 3476863994 Enrollment ID: I20151112000504 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Kennie R Rodriguez |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1275919789 PECOS PAC ID: 2668772666 Enrollment ID: I20151124000021 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Mary Jane Venzon |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1821489204 PECOS PAC ID: 4789901992 Enrollment ID: I20151130001078 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Bernice A Pritchett |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1700847449 PECOS PAC ID: 4183675150 Enrollment ID: I20160217002543 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Candice J Rosen |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1871958207 PECOS PAC ID: 2567768286 Enrollment ID: I20160307001525 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Alexandra Gabriel |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1184050767 PECOS PAC ID: 3577790864 Enrollment ID: I20160823002225 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jennifer Toro Galarza |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1720411598 PECOS PAC ID: 9335435023 Enrollment ID: I20160906002468 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Christopher R Buelvas |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1144659384 PECOS PAC ID: 3971899097 Enrollment ID: I20160915000959 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Haroldo Melo |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1457516254 PECOS PAC ID: 4880865088 Enrollment ID: I20160930001774 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Samantha Bonilla |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1174978175 PECOS PAC ID: 1355639543 Enrollment ID: I20161003002541 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Farhan Rehman |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1750722708 PECOS PAC ID: 8426350034 Enrollment ID: I20161011001281 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jorge M Rodriguez |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1952444648 PECOS PAC ID: 8022306596 Enrollment ID: I20161017000713 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jennifer Lyn Kramer |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1073974192 PECOS PAC ID: 2668766288 Enrollment ID: I20161028000889 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Mini Paul |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1740631639 PECOS PAC ID: 0042598716 Enrollment ID: I20161101000004 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jeneaurey Melendez |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1881022895 PECOS PAC ID: 0749569135 Enrollment ID: I20161107001810 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Lauren M Bedney |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1528497526 PECOS PAC ID: 2062640469 Enrollment ID: I20161109001657 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Naeem Ahmed |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1023453297 PECOS PAC ID: 7618107020 Enrollment ID: I20161212000840 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Stephanie M Williams |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1578006839 PECOS PAC ID: 7719269570 Enrollment ID: I20170131002123 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Nargiza Ayupova |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1356796858 PECOS PAC ID: 5092098806 Enrollment ID: I20170201001377 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Yekatherine Rasmussen |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1235345687 PECOS PAC ID: 1951493261 Enrollment ID: I20170306000526 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Mark Christopher Roque |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1467802892 PECOS PAC ID: 8729363361 Enrollment ID: I20170323000489 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Sunita Roque |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1255884409 PECOS PAC ID: 2668759820 Enrollment ID: I20170426001340 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Alexander L Kushnir |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1477970705 PECOS PAC ID: 5496025728 Enrollment ID: I20170719003436 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jason Michael Florimonte |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1538161518 PECOS PAC ID: 9739184011 Enrollment ID: I20170821003257 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Gregory E Baker |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1083654206 PECOS PAC ID: 1759318793 Enrollment ID: I20170831002888 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Paula Jean Knapp-baker |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1528167145 PECOS PAC ID: 8224059464 Enrollment ID: I20170901001277 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Hyrum Anthony Brodniak |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1619319563 PECOS PAC ID: 6709014681 Enrollment ID: I20171002001966 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Pamela A Couture |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1679953327 PECOS PAC ID: 5799097739 Enrollment ID: I20171010001144 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Ledy Clemencia Rojas Roldan |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1184722936 PECOS PAC ID: 5294837571 Enrollment ID: I20171018000345 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Sue-wei Luu |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1669819512 PECOS PAC ID: 8022251370 Enrollment ID: I20171104000071 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Kate L Leon |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1467970228 PECOS PAC ID: 0941566806 Enrollment ID: I20171108002940 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Gurpawan Dhaliwal |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1871889816 PECOS PAC ID: 4789807108 Enrollment ID: I20171127001802 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Tashrique Alam |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1821473299 PECOS PAC ID: 1658630637 Enrollment ID: I20180119001637 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Devlin H O'connor |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1053759035 PECOS PAC ID: 2365741105 Enrollment ID: I20180427001127 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Subha Jose |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1588192082 PECOS PAC ID: 1850655861 Enrollment ID: I20180427001139 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Dasrine K Gordon |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1295235943 PECOS PAC ID: 2860756699 Enrollment ID: I20180503000325 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Courtney M St. James |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1366853202 PECOS PAC ID: 1355643438 Enrollment ID: I20180723003337 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | William Gottschalk |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1306231873 PECOS PAC ID: 7618225855 Enrollment ID: I20180806000479 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Melissa Sepe |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1396222824 PECOS PAC ID: 3577814110 Enrollment ID: I20180920003530 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Arianna E Becker |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1205215985 PECOS PAC ID: 5799048161 Enrollment ID: I20181005002152 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Patricia Jean Pamas |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1104313469 PECOS PAC ID: 7113278276 Enrollment ID: I20181109002289 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Lisa Marie Peto |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1720485170 PECOS PAC ID: 8628348364 Enrollment ID: I20181110000089 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Daihla Perard Bastien |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1396130597 PECOS PAC ID: 0941544142 Enrollment ID: I20181128002993 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Susan Lynn Morse |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1467959700 PECOS PAC ID: 5092050187 Enrollment ID: I20181218001623 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Dominiqua Lint |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1053882290 PECOS PAC ID: 2264778349 Enrollment ID: I20190110000819 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jaclyn Ann Gunn |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1639548654 PECOS PAC ID: 9335431931 Enrollment ID: I20190115001419 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jessica Lynn Mcguire |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1043502529 PECOS PAC ID: 2264755321 Enrollment ID: I20190304001518 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Erin G Hough |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1013437706 PECOS PAC ID: 5193084325 Enrollment ID: I20190524000742 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Sue-ellen Elizabeth Griffith |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1083066187 PECOS PAC ID: 9739474073 Enrollment ID: I20190610000680 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jodi Wilder |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1336696327 PECOS PAC ID: 8426382615 Enrollment ID: I20190621000643 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Joey Darren Wilder |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1649644311 PECOS PAC ID: 7416204458 Enrollment ID: I20190621000884 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Robert Lee Solomon |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1073960357 PECOS PAC ID: 4486940582 Enrollment ID: I20190702002845 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Tamika Robertson |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1992254197 PECOS PAC ID: 2466788542 Enrollment ID: I20190726001752 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Lauren Marie Conroy |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1548623549 PECOS PAC ID: 9234426289 Enrollment ID: I20190812001270 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Katie Michele Sanford |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1336700434 PECOS PAC ID: 8628305760 Enrollment ID: I20190812002365 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Todd Wilson |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1790130862 PECOS PAC ID: 9931487790 Enrollment ID: I20190815002088 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Amanda Nadeau |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1164881009 PECOS PAC ID: 9537420047 Enrollment ID: I20190827003496 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Charles E Neetz |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1215489513 PECOS PAC ID: 9739460551 Enrollment ID: I20190905002771 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Melissa A Morello |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1700231719 PECOS PAC ID: 3173801958 Enrollment ID: I20190910000176 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Adam P Pasternak |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1295968311 PECOS PAC ID: 6103052717 Enrollment ID: I20190924002396 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Desirae Friend |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1447512199 PECOS PAC ID: 1658524202 Enrollment ID: I20191007000541 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Katrina Emilia Noboa |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1316594112 PECOS PAC ID: 5395077457 Enrollment ID: I20191023001581 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Angelic Alvarez |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1275983587 PECOS PAC ID: 3173819158 Enrollment ID: I20191030003156 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Kiet T La |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1083147862 PECOS PAC ID: 1052687837 Enrollment ID: I20200107002367 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Pamela Carlson |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1962032607 PECOS PAC ID: 7719314178 Enrollment ID: I20200224002270 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Kathleen Paige Dixon |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1720575632 PECOS PAC ID: 3173951993 Enrollment ID: I20200310000725 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Shana Lee Vongkhankeo |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1073144994 PECOS PAC ID: 1355770868 Enrollment ID: I20200405000006 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Joseph Johnson |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1760442834 PECOS PAC ID: 6002077633 Enrollment ID: I20200526000733 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Muhammad Sohel |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1992233837 PECOS PAC ID: 5496028979 Enrollment ID: I20200619000256 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Lei Gong |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1497934004 PECOS PAC ID: 5597818773 Enrollment ID: I20200715002302 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jennifer E Kelley |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1104359876 PECOS PAC ID: 4880954338 Enrollment ID: I20200716002562 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Christopher Lee Paik |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1548748957 PECOS PAC ID: 5193149557 Enrollment ID: I20200720001124 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jubeth Carlene Burlison |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1376077719 PECOS PAC ID: 0941560767 Enrollment ID: I20200728001605 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Pooja Shankar |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1093249906 PECOS PAC ID: 8224398417 Enrollment ID: I20200805002820 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Matthew D Ho |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1285168195 PECOS PAC ID: 8224398664 Enrollment ID: I20200807002897 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Maria Caratas Epstein |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1457714818 PECOS PAC ID: 1355671173 Enrollment ID: I20200821001673 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Steven M Pouls |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1063513687 PECOS PAC ID: 2860483443 Enrollment ID: I20200902000128 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Timothy Chan |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1487175535 PECOS PAC ID: 1153748314 Enrollment ID: I20200902001441 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Elizabeth Fisher |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1699156679 PECOS PAC ID: 5092028035 Enrollment ID: I20200909001355 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Stela Karkatselos |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1295342277 PECOS PAC ID: 7113347121 Enrollment ID: I20201119001154 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Marisha Sirdar |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1770016966 PECOS PAC ID: 5193097228 Enrollment ID: I20210205000118 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Erin Theresa Dorrer |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1336788165 PECOS PAC ID: 4385052364 Enrollment ID: I20210412000855 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Sarah Sakala |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1447892096 PECOS PAC ID: 9739589102 Enrollment ID: I20210608000248 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Wyniqua Brown |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1578021796 PECOS PAC ID: 7214279934 Enrollment ID: I20210628002167 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Yorlenis Rodriguez |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1043743297 PECOS PAC ID: 9032546262 Enrollment ID: I20210707003764 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Mariam Javed Mayet-khan |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1851897367 PECOS PAC ID: 5395177216 Enrollment ID: I20210721002282 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Alain Delgado Fuentes |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1770076283 PECOS PAC ID: 3678976826 Enrollment ID: I20210726001310 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Andrew Robert Ross |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1427558873 PECOS PAC ID: 7719380773 Enrollment ID: I20210728001808 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Trinh Duong Pham |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1174028047 PECOS PAC ID: 3476802331 Enrollment ID: I20210728002064 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jennifer C Dasque |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1881183168 PECOS PAC ID: 6709289580 Enrollment ID: I20210730003140 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Giselle I Pineiro |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1306323621 PECOS PAC ID: 0547664260 Enrollment ID: I20210803001576 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Carlos Romano |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1730679929 PECOS PAC ID: 7618217324 Enrollment ID: I20210816001602 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Alicia Abel |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1902432347 PECOS PAC ID: 5496150815 Enrollment ID: I20210824001510 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Samuel T. Fawaz |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1295945996 PECOS PAC ID: 8729179353 Enrollment ID: I20210901000969 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Mary Elizabeth Hafele-kott |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1225603038 PECOS PAC ID: 2860899978 Enrollment ID: I20210916000158 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jose Omar Burgos |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1053804997 PECOS PAC ID: 5092069435 Enrollment ID: I20210917001175 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Glenda Denisse Rosa Gonzalez |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1447564828 PECOS PAC ID: 3476880352 Enrollment ID: I20211012000713 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Sirirat Poontreeratn |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1316518640 PECOS PAC ID: 2264820588 Enrollment ID: I20211019001562 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Ramzi Zureikat |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1851529119 PECOS PAC ID: 1153577358 Enrollment ID: I20211021003173 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Ainslee Juarbe |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1932605276 PECOS PAC ID: 3971992017 Enrollment ID: I20211111001533 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Nina Theodora Camperlengo |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1609890128 PECOS PAC ID: 7113182387 Enrollment ID: I20211116002879 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Ryan Scott Tidwell |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1336712033 PECOS PAC ID: 0042609703 Enrollment ID: I20211118000758 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jacqueline Elizabeth Jenkins |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1619562147 PECOS PAC ID: 1355731985 Enrollment ID: I20211214000616 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Dawn A Taylor |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1184393183 PECOS PAC ID: 4587057740 Enrollment ID: I20220210001794 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Cheryl Adley Gulenay |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1538665559 PECOS PAC ID: 2365781069 Enrollment ID: I20220321000900 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Vola Harivony Le Roux |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1710422399 PECOS PAC ID: 2668755984 Enrollment ID: I20220322000195 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Katrina N Mcneal |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1518510965 PECOS PAC ID: 5294147989 Enrollment ID: I20220428000669 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | German Restrepo |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1023332848 PECOS PAC ID: 7810252103 Enrollment ID: I20220505002635 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Alissa Hogue |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1992181051 PECOS PAC ID: 8426367897 Enrollment ID: I20220507000206 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Christina Bowman |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1922740802 PECOS PAC ID: 5698152411 Enrollment ID: I20220517002698 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Chloe Louise Kindred |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1790348191 PECOS PAC ID: 6507108792 Enrollment ID: I20220607002210 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Morgan Macintyre |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1427517432 PECOS PAC ID: 2365879913 Enrollment ID: I20220613002604 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Oscar Radi |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1700438454 PECOS PAC ID: 5496134900 Enrollment ID: I20220614000061 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Hetalben Bhatt |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1255089645 PECOS PAC ID: 2769861830 Enrollment ID: I20220620002074 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Omari Hodge |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1538470646 PECOS PAC ID: 2062690340 Enrollment ID: I20220708003512 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Tracey Ray Adams |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1376882225 PECOS PAC ID: 2567609472 Enrollment ID: I20220712002939 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Jacob W Albert |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1265929319 PECOS PAC ID: 4183974561 Enrollment ID: I20220713004275 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Tania Mowatt |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1124580451 PECOS PAC ID: 1052792553 Enrollment ID: I20220714002857 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Ahmad Emara |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1477013613 PECOS PAC ID: 2860726452 Enrollment ID: I20220718000722 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Laraey King |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1538622691 PECOS PAC ID: 6305171919 Enrollment ID: I20220720002372 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Nancy Si |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1265992705 PECOS PAC ID: 1658608625 Enrollment ID: I20220802000192 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Nora Helen Quattrocelli |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1275039083 PECOS PAC ID: 3577828730 Enrollment ID: I20220802002530 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Amber Hill |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1548721384 PECOS PAC ID: 6305172933 Enrollment ID: I20220803000241 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Andrea Claire Miser |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1528562584 PECOS PAC ID: 3870975030 Enrollment ID: I20220804000600 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Tamara Sealy |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1225477094 PECOS PAC ID: 6103138862 Enrollment ID: I20220809000077 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Vamsi Nukala |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1669737706 PECOS PAC ID: 6204149800 Enrollment ID: I20220817000444 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | James Pense |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1962898775 PECOS PAC ID: 4082922463 Enrollment ID: I20220817002182 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Varna Davalath |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1538723499 PECOS PAC ID: 6103168380 Enrollment ID: I20220824001096 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Paras Bajaj |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1972066736 PECOS PAC ID: 6103209192 Enrollment ID: I20220824002576 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Shabnam Siddiqui |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1144883398 PECOS PAC ID: 5597007328 Enrollment ID: I20220829000820 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Amanda A Hussein |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1518528124 PECOS PAC ID: 1355670530 Enrollment ID: I20220829003607 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Nicholas Pantelis |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1992265110 PECOS PAC ID: 2466783071 Enrollment ID: I20220830000144 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Dmitry Aleks Drapach |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1669487542 PECOS PAC ID: 9032205331 Enrollment ID: I20220830000398 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Zaynab Rasheed |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1437688538 PECOS PAC ID: 2769755032 Enrollment ID: I20220901002230 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Stephanie Mathis |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1295499572 PECOS PAC ID: 0749664092 Enrollment ID: I20220906000430 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Kassie Falcon |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1972064780 PECOS PAC ID: 9931439692 Enrollment ID: I20220908000784 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Rachel White |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1538892567 PECOS PAC ID: 0345625406 Enrollment ID: I20220911000020 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Magdeley Mordan |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1932757101 PECOS PAC ID: 4284019118 Enrollment ID: I20220913004076 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Candice Galnares Soto |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1982335808 PECOS PAC ID: 3274918446 Enrollment ID: I20220923003031 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Loira Enid Gonzalez |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1366903189 PECOS PAC ID: 6103292164 Enrollment ID: I20221014003052 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Alicia Benjamin |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1134697592 PECOS PAC ID: 0941537831 Enrollment ID: I20221018001658 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Allison Michelle Craig |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1578292637 PECOS PAC ID: 2365811437 Enrollment ID: I20221212002208 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Darshan Patel |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1336466200 PECOS PAC ID: 1052532496 Enrollment ID: I20221214002015 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Sunil Bharwani |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1699967877 PECOS PAC ID: 9537242250 Enrollment ID: I20221228001719 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Gabrielle Ramos |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1861101495 PECOS PAC ID: 8820460488 Enrollment ID: I20230207003009 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Prasanthi Marella |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1548407810 PECOS PAC ID: 6406908268 Enrollment ID: I20230211000219 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Sarah Mcandrew |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1679921548 PECOS PAC ID: 3971899956 Enrollment ID: I20230223002816 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Zachary Strickland |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1487048021 PECOS PAC ID: 5395032551 Enrollment ID: I20230309001697 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Isabella Caterina Katz |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1235845512 PECOS PAC ID: 0941675326 Enrollment ID: I20230418000030 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Anjali Hardeo |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1568025088 PECOS PAC ID: 0941623128 Enrollment ID: I20230418002736 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Manju Kanikunnel |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1942615851 PECOS PAC ID: 1658599493 Enrollment ID: I20230531002456 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Sylvia Ann Bozeman |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1467976928 PECOS PAC ID: 0648638437 Enrollment ID: I20230627001642 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Asheema Bacchus |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1699209296 PECOS PAC ID: 3476824707 Enrollment ID: I20230711002756 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Trevor A Owens |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1942839386 PECOS PAC ID: 8527485879 Enrollment ID: I20230720003587 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Alejandro Pelaez |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1942821343 PECOS PAC ID: 4486075686 Enrollment ID: I20230725000626 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Monica Mansour |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1427679513 PECOS PAC ID: 3971924937 Enrollment ID: I20230728002674 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Andrew Brendan Dill |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1215922182 PECOS PAC ID: 8921012139 Enrollment ID: I20230804000268 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Christopher Polonio |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1972126530 PECOS PAC ID: 6103298484 Enrollment ID: I20230804001305 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Celeste Vickery |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1780211821 PECOS PAC ID: 8426470931 Enrollment ID: I20230804001426 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Maria Cecilia Lopez Craig |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1295354231 PECOS PAC ID: 1658792254 Enrollment ID: I20230807002290 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Manuel Calcagno Casasnovas |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1023647344 PECOS PAC ID: 6406218429 Enrollment ID: I20230808002544 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Nilesh Prakash Dialani |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1972120582 PECOS PAC ID: 3274956420 Enrollment ID: I20230817003714 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Anne Marie Rhoton |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1952787251 PECOS PAC ID: 7416257753 Enrollment ID: I20230828000072 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Anna Millan |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1669549572 PECOS PAC ID: 7012977655 Enrollment ID: I20230831000247 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Austin Rand Shoener |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1346733011 PECOS PAC ID: 9739573684 Enrollment ID: I20230907002642 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Pamela Jean Bacom |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1275225898 PECOS PAC ID: 4284088477 Enrollment ID: I20230921001822 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Stamatis Damalos |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1407485071 PECOS PAC ID: 9436503679 Enrollment ID: I20230921003821 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Nicole Elizabeth Woodel Shoener |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1386164473 PECOS PAC ID: 1850714650 Enrollment ID: I20230926001311 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Daniel O'bryan |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1497315592 PECOS PAC ID: 3971926809 Enrollment ID: I20230929001883 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Farhan Siddiqui |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1033537865 PECOS PAC ID: 3870892383 Enrollment ID: I20231006001877 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Cha Lee |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1285743971 PECOS PAC ID: 9234137563 Enrollment ID: I20231010000327 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Adam Cerissi |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1114488384 PECOS PAC ID: 3779932371 Enrollment ID: I20231207003107 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Sonia Kanacheril |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1699303487 PECOS PAC ID: 3678998598 Enrollment ID: I20240103000098 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Nicholas A Landers |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1164206413 PECOS PAC ID: 5294186235 Enrollment ID: I20240104000182 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Sandra Fermina Rosario Cruz |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1558134692 PECOS PAC ID: 6002268380 Enrollment ID: I20240123001581 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Hannah Anderson |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1295398667 PECOS PAC ID: 4082099593 Enrollment ID: I20240124004932 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Melissa Ann Lovemore Wright |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1770369332 PECOS PAC ID: 8921451980 Enrollment ID: I20240126000960 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Provider Name | Deborah Conran |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1699775056 PECOS PAC ID: 1759461981 Enrollment ID: I20240311001852 |
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
News Archive
Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on
Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
A new study by researchers from the UK and Germany and published on the preprint server bioRxiv in June 2020 reports the results of a detailed study of the S protein on the intact virus, using cryoelectron microscopy (cryoEM) and tomography. This could help understand the conformation of the S protein on the virion and how it interacts with neutralizing antibodies.
› Verified 9 days ago
Gregory P Samano Ii Do Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 499 E Central Pkwy Ste 100, Altamonte Springs, FL 32701 Phone: 407-543-3461 Fax: 407-678-0627 | |
Mark E. Weigley, M.d., P.a. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 685 Palm Springs Dr, Suite 1a, Altamonte Springs, FL 32701 Phone: 407-339-5959 Fax: 407-339-5951 | |
Beach Medical X4 Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 104 Marcia Dr, Altamonte Springs, FL 32714 Phone: 407-502-0073 | |
Mueller Institute For Holistic Medicine Plc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 251 Maitland Ave, Ste. 104, Altamonte Springs, FL 32701 Phone: 407-332-5703 Fax: 407-332-5744 | |
Cogent Healthcare Of Pensacola Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 601 E Altamonte Dr, Altamonte Springs, FL 32701 Phone: 407-303-2200 | |
Ocean Blue Medspa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 195 S Westmonte Dr Ste 1120, Altamonte Springs, FL 32714 Phone: 407-885-1515 |